Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein

British Journal of Pharmacology

Volumn 139, Issue 8, 2003, Pages 1409-1416

  Daray, Federico Manuel ^a   Minvielle, Ana Itatí ^a   Puppo, Soledad ^a   Rothlin, Rodolfo Pedro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fluprostenol; FP receptors; Human umbilical vein; ICI 192,605; Prostanoid receptors; SQ 29548; TP receptors; U 46619; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 17 PHENYL TRINORPROSTAGLANDIN E2; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ICI 192 605; MISOPROSTOL; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UMBILICAL VEIN; VENOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; DIOXANES; HUMANS; HYDRAZINES; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE; UMBILICAL VEINS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0141763525     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705375     Document Type: Article

References (45)

1. ALTURA, B.M., MALAVIYA, D., REICH, C.F. & ORKIN, L.R. (1972). Effects of vasoactive agents on isolated human umbilical arteries and veins. Am. J. Physiol., 222, 345-355.
2. ANGULO, J., CUEVAS, P., LA FUENTE, J.M., POMEROL, J.M., RUIZ-CASTANE, E., PUIGVERT, A., GABANCHO, S., FERNANDEZ, A., NEY, P. & SAENZ DE TEJADA, I. (2002). Regulation of human penile smooth muscle tone by prostanoid receptors. Br. J. Pharmacol., 136, 23-30.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-52.
4. BAXTER, G.S., CLAYTON, J.K., COLEMAN, R.A., MARSHALL, K., SANGHA, R. & SENIOR, J. (1995). Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Br. J. Pharmacol., 116, 1692-1696.
5. BIBBY, J.G., BRUNT, J.D., HODGSON, H., MITCHELL, M.D., ANDERSON, A.B. & TURNBULL, A.C. (1979). Prostaglandins in umbilical plasma at elective caesarean section. Br. J. Obstet, Gynaecol., 86, 282-284.
6. BJORO, K., HOVIG, T., STOKKE, K.T. & STRAY-PEDERSEN, S. (1986). Formation of prostanoids in human umbilical vessels perfused in vitro. Prostaglandins, 31, 683-698.
7. BOERSMA, J.I., JANZEN, K.M., OLIVEIRA, L. & CRANKSHAW, D.J. (1999). Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br. J. Pharmacol., 128, 1505-1512.
8. BOURA, A.L., GUDE, N.M., KING, R.G., MAK, K.K. & WALTERS, W.A. (1986). Characterization of thromboxane A2 receptors in the human fetal placental vessels and umbilical vein. Clin. Exp. Pharmacol. Physiol., 13, 83-86.
9. CAMACHO, M., LOPEZ-BELMONTE, J. & VILA, L. (1998). Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ. Res., 83, 353-365.
10. COLEMAN, R.A., HUMPHREY, P.P., KENNEDY, I., LEVY, G.P. & LUMLEY, P. (1981). Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br. J. Pharmacol., 73, 773-778.
11. 2 sensitive (EP) receptors in smooth muscle. Br. J. Pharmacol., 91, 323P.
12. COLEMAN, R.A. & SHELDRICK, R.L. (1989). Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br. J. Pharmacol., 96, 688-692.
13. COLEMAN, R.A., SMITH, W.L. & NARUMIYA, S. (1994). VIII. International Union of Pharmacology Classification of Prostanoid Receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.
14. DE GROOT, C.J., MURAI, J.T., VIGNE, J.L. & TAYLOR, R.N. (1998). Eicosanoid secretion by human endothelial cells exposed to normal pregnancy and preeclampsia plasma in vitro. Prostaglandins Leukot. Essent. Fatty Acids, 58, 91-97.
15. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
16. DUBIN, N.H., JOHNSON, J.W., CALHOUN, S., GHODGAONKAR, R.B. & BECK, J.C. (1981). Plasma prostaglandin in pregnant women with term and preterm deliveries. Obstet. Gynecol., 57, 203-206.
17. 1-adrenoceptor subtypes mediating contraction in human umbilical vein. Br. J. Pharmacol., 126, 437-442.
18. FOX, S.B. & KHONG, T.Y. (1990). Lack of innervation of human umbilical cord. An immunohistological and histochemical study. Placenta, 11, 59-62.
19. GRIFFIN, B.W., KLIMKO, P., CRIDER, J.Y. & SHARIF, N.A. (1999). AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J. Pharmacol. Exp. Ther., 290, 1278-1284.
20. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPHREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
21. 2 receptor antagonist, on platelets. Br. J. Pharmacol., 95, 676P.
22. JINO, H., KURAHASHI, K., USUI, H., NAKATA, Y., SHIMIZU, Y. & TEMMA, S. (1996). Pharmacological nature of TP receptor mediated contraction in human intrapulmonary artery. Life Sci., 59, 2059-2065.
23. JONES, R.L., QIAN, Y.M., CHAN, K.M. & YIM, A.P. (1998). Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Br. J. Pharmacol., 125, 1288-1296.
24. 2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J. Pharmacol. Exp. Ther., 304, 238-245.
25. KIRIYAMA, M., USHIKUBI, F., KOBAYASHI, T., HIRATA, M., SUGIMOTO, Y. & NARUMIYA, S. (1997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol., 122, 217-224.
26. LACHNIT, W.G., TRAN, A.M., CLARKE, D.E. & FORD, A.P. (1997). Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol., 120, 819-826.
27. LAWRENCE, R.A., JONES, R.L. & WILSON, N.H. (1992). Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br. J. Pharmacol., 105, 271-278.
28. LIU, H.S., CHU, T.Y., YU, M.H., CHANG, Y.K., KO, C.S. & CHAO, C.F. (1998). Thromboxane and prostacyclin in maternal and fetal circulation in pre-eclampsia. Int. J. Gynaecol. Obstet., 63, 1-6.
29. MITCHELL, M.D., BRUNT, J., BIBBY, J., FLINT, A.P., ANDERSON, A.B. & TURNBULL, A.C. (1978). Prostaglandins in the human umbilical circulation at birth. Br. J. Obstet. Gynaecol., 85, 114-118.
30. OGLETREE, M.L., HARRIS, D.N., GREENBERG, R., HASLANGER, M.F. & NAKANE, M. (1985). Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J. Pharmacol. Exp. Ther., 234, 435-441.
31. PALEA, S., TOSON, G., PIETRA, C., TRIST, D.G., ARTIBANI, W., ROMANO, O. & CORSI, M. (1998). Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br. J. Pharmacol., 124, 865-872.
32. QIAN, Y.M., JONES, R.L., CHAN, K.M., STOCK, A.I. & HO, J.K. (1994). Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Br. J. Pharmacol., 113, 369-374.
33. REILLY, F.D. & RUSSELL, P.T. (1977). Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat. Rec., 188, 277-286.
34. 1B receptors using functional studies. Naunyn-Schmiedebergs Arch. Pharmacol., 366, 596-604.
35. 2A receptors using functional and radioligand binding assays. Naunyn-Schmiedeberg's Arch. Pharmacol., 366, 587-595.
36. 1 receptors in human umbilical vein. Eur. J. Pharmacol., 321, 33-38.
37. SENCHYNA, M. & CRANKSHAW, D.J. (1996). Characterization of the prostanoid TP receptor population in human nonpregnant myometrium. J. Pharmacol. Exp. Ther., 279, 262-270.
38. SENIOR, J., MARSHALL, K., SANGHA, R. & CLAYTON, J.K. (1993). In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol., 108, 501-506.
39. SHARIF, N.A., WILLIAMS, G.W. & KELLY, C.R. (2001). Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur. J. Pharmacol., 432, 211-213.
40. SPIVACK, M. (1946). The anatomic peculiarities of the human umbilical cord and their clinical significance. Am. J. Obstet. Gynecol., 52, 387-401.
41. TANG, L., LOUTZENHISER, K. & LOUTZENHISER, R. (2000). Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: role of EP(3) and EP(4) receptors. Circ. Res., 86, 663-670.
42. WALCH, L, DE MONTPREVILLE, V., BRINK, C. & NOREL, X. (2001). Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Br. J. Pharmacol., 134, 1671-1678.
43. WALSH, S.W. (1985). Preeelampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol., 152, 335-340.
44. WATANABE, K., NAGASAWA, N., WEN, F.Q., INOUE, K., KURODA, K. & YOSHIDA, M. (1997). Azelastine suppresses the release of arachidonic acid metabolites from cultured human umbilical vein endothelial cells. Prostaglandins Leukot. Essent. Fatty Acids, 56, 209-211.
45. WRIGHT, D.H., ABRAN, D., BHATTACHARYA, M., HOU, X., BERNIER, S.G., BOUAYAD, A., FOURON, J.C., VAZQUEZ-TELLO, A., BEAUCHAMP, M.H., CLYMAN, R.I., PERI, K., VARMA, D.R. & CHEMTOB, S. (2001). Prostanoid receptors: ontogeny and implications in vascular physiology. Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, 1343-1360.